News

Press Releases

Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia
Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Asuragen to Present at 2016 Association for Molecular Pathology Annual Meeting
Asuragen Develops Armored RNA Quant® Zika Virus Control
Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia
Asuragen Launches the AmplideX® PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Asuragen Launches AmplideX® PCR/CE FMR1 Reporter*, a Fully Automated Software Solution for Accurate Sizing of the FMR1 CGG Repeat Region
Asuragen to Collaborate with Illumina on Companion Diagnostics Development
Asuragen to join leading UK cancer research consortium to develop miRNA based sequencing tests for early detection and screening of cancer

About

Back To
Top